세계의 아피게닌 시장

Global Apigenin Market to Reach US$359.5 Thousand by 2030

The global market for Apigenin estimated at US$313.6 Thousand in the year 2024, is expected to reach US$359.5 Thousand by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. 0.95 Purity Level, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$209.4 Thousand by the end of the analysis period. Growth in the 0.98 Purity Level segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.4 Thousand While China is Forecast to Grow at 4.5% CAGR

The Apigenin market in the U.S. is estimated at US$85.4 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$68.7 Thousand by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Apigenin Market - Key Trends & Drivers Summarized

Why Is Apigenin Gaining Prominence Across Diverse Industries?

Apigenin, a naturally occurring flavonoid found in various plant sources such as chamomile, parsley, celery, and citrus fruits, is gaining widespread attention for its applications across pharmaceuticals, nutraceuticals, cosmetics, and functional food industries. As consumer preferences shift toward plant-derived bioactive compounds, apigenin is emerging as a highly sought-after ingredient due to its potential health-promoting properties and increasing scientific validation. The demand for botanical extracts in the pharmaceutical sector has surged, with apigenin being explored for its potential in oncology, cardiovascular health, and neuroprotection. Meanwhile, the functional food and nutraceutical industry has embraced apigenin as a key ingredient in dietary supplements aimed at promoting overall wellness and longevity. Additionally, the clean beauty movement has further propelled its use in skincare and personal care formulations, where it is being integrated into anti-aging creams, serums, and UV-protection formulations. The expanding consumer awareness regarding natural and plant-based ingredients is reinforcing the prominence of apigenin, positioning it as a crucial component in holistic health and wellness solutions.

How Are Technological Innovations Enhancing Apigenin Extraction and Formulation?

The advancement of extraction technologies and formulation techniques has played a pivotal role in improving the commercial viability of apigenin for industrial applications. Traditional solvent extraction methods are now being supplemented with more efficient approaches such as supercritical fluid extraction, ultrasound-assisted extraction (UAE), and enzymatic hydrolysis, which enhance yield, purity, and bioavailability. Furthermore, advancements in nanotechnology and encapsulation techniques, such as liposomal and polymeric nanoparticle delivery systems, have significantly improved the stability and absorption of apigenin in both pharmaceutical and cosmetic formulations. These innovations have made it possible to develop apigenin-based products with enhanced bioefficacy and controlled-release mechanisms, increasing its applicability across multiple sectors. Additionally, AI-driven formulation techniques are enabling manufacturers to optimize apigenin-based compounds for targeted therapeutic applications, reducing production costs and improving scalability. The integration of biotechnology, particularly microbial biosynthesis, is also paving the way for sustainable and consistent production of apigenin, reducing dependence on seasonal plant sources and improving supply chain resilience. As technological advancements continue to enhance extraction efficiency and formulation stability, apigenin is set to become a mainstream bioactive compound in the health and wellness industry.

What Market Trends Are Driving the Demand for Apigenin-Based Products?

Several key market trends are shaping the demand for apigenin-based products, particularly in the nutraceutical, pharmaceutical, and personal care industries. The increasing consumer inclination toward natural and organic ingredients has led to a surge in demand for plant-derived bioactives, positioning apigenin as a preferred alternative to synthetic compounds in dietary supplements and functional foods. The growing popularity of nootropics and cognitive-enhancing supplements has further fueled interest in apigenin, with research supporting its role in cognitive health and neuroprotection. Meanwhile, the skincare industry is witnessing a shift towards botanically sourced ingredients, driving the incorporation of apigenin into anti-aging, antioxidant-rich, and anti-inflammatory skincare formulations. The rise of personalized nutrition and precision medicine has also contributed to the expansion of the apigenin market, as scientific research continues to uncover its role in targeted health applications. Additionally, regulatory shifts promoting the use of naturally occurring flavonoids in functional foods and pharmaceuticals have facilitated market entry for apigenin-based products. The increasing penetration of e-commerce and direct-to-consumer (DTC) wellness brands has further accelerated the adoption of apigenin, making it more accessible to health-conscious consumers worldwide. These evolving trends indicate a sustained market trajectory, with apigenin poised for significant growth across multiple consumer-driven industries.

What Are the Key Growth Drivers Fueling the Apigenin Market Expansion?

The growth in the apigenin market is driven by several factors, including advancements in extraction and formulation technologies, increasing consumer demand for botanical-based supplements, and the expanding application scope in pharmaceuticals, nutraceuticals, and cosmetics. The rising investment in clinical research supporting apigenin’s therapeutic potential is encouraging pharmaceutical companies to explore new drug formulations incorporating this bioactive flavonoid. The functional food and beverage industry’s expansion, particularly in regions such as North America, Europe, and Asia-Pacific, is contributing to higher demand for apigenin-enriched products targeting immune support, cognitive function, and metabolic health. Additionally, the clean beauty movement and sustainability-driven innovations in skincare are further accelerating apigenin’s adoption in cosmetic formulations. The increasing regulatory approvals for flavonoid-based functional ingredients are facilitating global market growth, prompting companies to focus on compliance, safety, and efficacy to meet evolving consumer expectations. The rapid growth of digital health platforms and personalized wellness solutions is also shaping market trends, allowing consumers to access apigenin-based products tailored to their specific health needs. With ongoing innovations, expanding industry applications, and evolving consumer preferences, the apigenin market is set for continuous expansion, offering new opportunities for manufacturers and stakeholders across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Apigenin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (0.95 Purity Level, 0.98 Purity Level, Other Types): Application (Pharma & Healthcare Application, Food Additives Application, Cosmetic & Skin Care Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Anhui Sinotech Industrial
• Cayman Chemical Company
• Chengdu Chenlv Biological Technology
• Codeage LLC
• Enzo Life Sciences, Inc.
• Fuyang Bestop Import And Export Ltd.
• Glentham Life Sciences Ltd.
• HealthTech BioActives
• Hello Bio Ltd.
• INDOFINE Chemical Company, Inc.
• Jinan Tantu Chemicals
• Lanyor Biotech Co., Ltd.
• Mianyang Di'ao Pharmaceutical Co., Ltd.
• S. Nihar Exports
• Selleck Chemicals
• Shaanxi Pioneer Biotech Co., Ltd.
• Sunriver Biotech
• Wuhan Hengheda Pharm Co., Ltd.
• Xi'an Arisun ChemPharm Co., Ltd.
• Xi'an Bettering Biotech Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Apigenin - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Interest in Flavonoid-Based Natural Compounds Spurs Demand for Apigenin in Dietary Supplements
  • Growing Scientific Validation of Anti-Inflammatory and Antioxidant Benefits Strengthens Business Case for Apigenin
  • Expansion of Nutraceutical and Functional Food Sectors Accelerates Inclusion of Apigenin as a Bioactive Ingredient
  • Increased Consumer Focus on Natural Health Products Throws the Spotlight on Botanical Extracts Like Apigenin
  • Advancements in Extraction and Purification Technologies Drive Cost-Efficient and High-Purity Production
  • Rising Interest in Plant-Based Ingredients in Cosmetics and Personal Care Fuels Use of Apigenin in Skincare Formulations
  • Surge in Cancer Research and Preclinical Studies Expands Therapeutic Interest in Apigenins Cytoprotective Properties
  • Growth in Herbal Drug Development and TCM Integration Generates New Use-Cases for Apigenin
  • Regulatory Support for Natural Antioxidants in Food Preservation Drives Adoption in Clean Label Foods
  • Demand for Neuroprotective and Cognitive Health Supplements Accelerates Application of Apigenin in Brain Health
  • Expansion of Vegan and Plant-Based Nutrition Trends Creates Favorable Market Conditions
  • Increasing Inclusion of Apigenin in Sports and Performance Nutrition Formulations Sustains Growth
  • Collaboration Between Supplement Manufacturers and Botanical Research Institutions Enhances Product Innovation
  • Availability of Apigenin in Multiple Delivery Formats Broadens Consumer Appeal
  • Growing Demand for Immune-Boosting and Anti-Aging Products Strengthens Market for Bioflavonoid Compounds
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Apigenin Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Apigenin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Apigenin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for 0.95 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for 0.95 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for 0.95 Purity Level by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for 0.98 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for 0.98 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for 0.98 Purity Level by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 14: USA Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 15: USA Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: USA 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 17: Canada Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 18: Canada Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: Canada 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• JAPAN
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Japan Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: Japan 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• CHINA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 23: China Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 24: China Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: China 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• EUROPE
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 26: Europe Recent Past, Current & Future Analysis for Apigenin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: Europe Historic Review for Apigenin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: Europe 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 29: Europe Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 30: Europe Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: Europe 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• FRANCE
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 32: France Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: France Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: France 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• GERMANY
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 35: Germany Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Germany Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: Germany 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 38: Italy Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Italy Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: Italy 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 41: UK Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: UK Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: UK 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 44: Spain Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Spain Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: Spain 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 47: Russia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Russia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: Russia 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Rest of Europe Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Rest of Europe 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 54: Asia-Pacific Historic Review for Apigenin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Asia-Pacific 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Asia-Pacific 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 59: Australia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Australia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Australia 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• INDIA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 62: India Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: India Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: India 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 65: South Korea Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: South Korea Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: South Korea 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Rest of Asia-Pacific Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 71: Latin America Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 72: Latin America Historic Review for Apigenin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Latin America 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 74: Latin America Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Latin America Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Latin America 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 77: Argentina Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Argentina Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Argentina 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 80: Brazil Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Brazil Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Brazil 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 83: Mexico Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Mexico Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: Mexico 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Rest of Latin America Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: Rest of Latin America 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 89: Middle East Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 90: Middle East Historic Review for Apigenin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: Middle East 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 92: Middle East Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Middle East Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Middle East 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 95: Iran Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Iran Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Iran 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 98: Israel Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Israel Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Israel 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Saudi Arabia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Saudi Arabia 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 104: UAE Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: UAE Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: UAE 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Rest of Middle East Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Rest of Middle East 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
• AFRICA
  • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 110: Africa Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Africa Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: Africa 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION